The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future
- PMID: 35525982
- PMCID: PMC9078090
- DOI: 10.1186/s13027-022-00434-2
The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future
Abstract
Various investigations have expanded the views that tuberculosis is an important risk factor for lung cancer occurrence. Lung cancer originates from chronic inflammation and infection. It is becoming clearer that Mycobacterium tuberculosis (M.tb) in tuberculosis patients meticulously schemes multiple mechanisms to induce tumor formation and is indispensable to participate in the occurrence of lung cancer. In addition, some additional factors such as age, sex and smoking, accelerate the development of lung cancer after Mycobacterium tuberculosis infection. The clarification of these insights is fostering new diagnoses and therapeutic approaches to prevention of the patients developing from tuberculosis into lung cancer.
Keywords: COX-2; CRP; Cytokine; DNA damage; Lung cancer; ROS; Risk factor; Tuberculosis.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Effects of age on the association between pulmonary tuberculosis and lung cancer in a South Korean cohort.J Thorac Dis. 2020 Mar;12(3):375-382. doi: 10.21037/jtd.2020.01.38. J Thorac Dis. 2020. PMID: 32274103 Free PMC article.
-
[Recent progress in mycobacteriology].Kekkaku. 2007 Oct;82(10):783-99. Kekkaku. 2007. PMID: 18018602 Japanese.
-
[Frontier of mycobacterium research--host vs. mycobacterium].Kekkaku. 2005 Sep;80(9):613-29. Kekkaku. 2005. PMID: 16245793 Japanese.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Advances in molecular mechanisms of interaction between Mycobacterium tuberculosis and lung cancer: a narrative review.Transl Lung Cancer Res. 2021 Oct;10(10):4012-4026. doi: 10.21037/tlcr-21-465. Transl Lung Cancer Res. 2021. PMID: 34858788 Free PMC article. Review.
Cited by
-
Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches.Diseases. 2024 Sep 3;12(9):202. doi: 10.3390/diseases12090202. Diseases. 2024. PMID: 39329871 Free PMC article. Review.
-
Risk of Lung Cancer and Risk Factors of Lung Cancer in People Infected with Tuberculosis.J Cancer Prev. 2024 Dec 30;29(4):157-164. doi: 10.15430/JCP.24.016. J Cancer Prev. 2024. PMID: 39790229 Free PMC article.
-
Research progress on lung cancer complicated with pulmonary tuberculosis: a narrative review.Transl Lung Cancer Res. 2025 Jun 30;14(6):2272-2280. doi: 10.21037/tlcr-2025-450. Epub 2025 Jun 24. Transl Lung Cancer Res. 2025. PMID: 40673073 Free PMC article. Review.
-
Antimycobacterial and Anticancer Properties of Myrtus communis Leaf Extract.Pharmaceuticals (Basel). 2024 Jul 2;17(7):872. doi: 10.3390/ph17070872. Pharmaceuticals (Basel). 2024. PMID: 39065723 Free PMC article.
-
Clinical characteristics of patients simultaneously diagnosed with lung cancer and active pulmonary tuberculosis in countries where tuberculosis is moderately endemic.Transl Cancer Res. 2022 Aug;11(8):2480-2482. doi: 10.21037/tcr-22-1904. Transl Cancer Res. 2022. PMID: 36093510 Free PMC article. No abstract available.
References
-
- Bae S, Kim YJ, Kim MJ, Kim JH, Yun SC, Jung J, Kim MJ, Chong YP, Kim SH, Choi SH, et al. Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study. J Immunother Cancer. 2021;9(9):e002960. doi: 10.1136/jitc-2021-002960. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous